Effect of serum from patients with ST-segment elevation myocardial infarction on endothelial cells.

Grupos y Plataformas de I+D+i
Abstract
INTRODUCTION AND OBJECTIVES: Clinical and experimental studies have shown that, in patients with reperfused ST-segment elevation myocardial infarction (STEMI), abnormalities in the endothelial monolayer are initiated during ischemia but rapidly intensify upon restoration of blood perfusion to the ischemic area. We aimed to evaluate the effect of serum isolated after revascularization from STEMI patients on the degree of endothelial permeability in vitro, by promoting endothelial cell apoptosis and necrosis in vitro. We also investigated the association between the percentage of serum-induced endothelial cell apoptosis or necrosis in vitro and the extent of cardiovascular magnetic resonance (CMR)-derived parameters of reperfusion injury (edema, hemorrhage, and microvascular obstruction). METHODS: Human coronary artery endothelial cells were incubated with serum isolated 24hours after revascularization from 43 STEMI patients who underwent CMR and 14 control participants. We assessed the effect of STEMI serum on activation of apoptosis and necrosis, as well as on the permeability and structure of the endothelial monolayer. RESULTS: Serum from STEMI patients increased apoptosis (P <.01) and necrosis (P <.05) in human coronary artery endothelial cells and caused increased permeability of the endothelial monolayer in vitro (P <.01), due to enlarged intercellular spaces (P <.05 vs control in all cases). Higher serum-induced necrosis was associated with greater endothelial permeability in vitro (P <.05) and with more extensive CMR-derived indices of reperfusion injury and infarct size. CONCLUSIONS: Postreperfusion serum activates necrosis and apoptosis in endothelial cells and increases the degree of endothelial permeability in vitro. The more potent the necrosis-triggering effect of serum, the more deleterious the consequences in terms of the resulting cardiac structure.
Copyright © 2023 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 1885-5857, 1579-2242
- Tipo:
- Article
- Páginas:
- 254-264
- PubMed:
- 37696331
REVISTA ESPANOLA DE CARDIOLOGIA Elsevier Doyma
Citas Recibidas en Web of Science: 5
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Keywords
- Células endoteliales; Daño por reperfusión; Endothelial cells; Endothelial permeability; Infarto de miocardio; Myocardial infarction; Permeabilidad endotelial; Reperfusion injury
Financiación
Proyectos y Estudios Clínicos
Resolution of microvascular obstruction after myocardial infarction. A multidisciplinary approach to assess the structural and clinical consequences and to evaluate new therapeutic options.
Investigador Principal: VICENT BODÍ PERIS
PI20/00637 . INSTITUTO SALUD CARLOS III . 2021
A multidisciplinary study to advance in the understanding of the basic mechanisms and clinical implications of microvascular obstruction after acute myocardial infarction. Exploration of novel diagnostic and therapeutic opportunities.
Investigador Principal: VICENT BODÍ PERIS
PROMETEO/2021/008 . CONSELLERIA EDUCACION/INNOVACION,UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL/EMPLEO . 2021
MEDICINA DE PRECISIÓN MEDIANTE RESONANCIA MAGNÉTICA CARDÍACA EN PACIENTES TRAS INFARTO AGUDO DE MIOCARDIO CON ELEVACIÓN DEL SEGMENTO ST: UTILIDAD CLÍNICA EN SITUACIONES ESPECIALES.
Investigador Principal: VICTOR MARCOS GARCÉS
CIGE/2022/26 . CONSELLERIA EDUCACION/INNOVACION,UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL/EMPLEO . 2023
Cita
Ríos C,Gavara J,de Dios E,Pérez N,Molina T,Marcos V,Ruiz A,Bayés A,Carrión F,Chorro FJ,Bodí V. Effect of serum from patients with ST-segment elevation myocardial infarction on endothelial cells. Rev. Esp. Cardiol. 2024. 77. (3):p. 254-264. IF:4,900. (1).
Effect of serum from patients with ST-segment elevation myocardial infarction on endothelial cells. Ríos C, Gavara J, de Dios E, Pérez N, Molina T, Marcos V, Ruiz A et al. REVISTA ESPANOLA DE CARDIOLOGIA. 2024 marzo 01. 77 (3):254-264. DOI:10.1016/j.rec.2023.08.004. PMID:37696331.